Autres langues WuXi Biologics (Cayman) Inc.

Actions

2269

KYG970081173

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:09:05 07/06/2024			Varia. 5j.	Varia. 1 janv.
11,38 ^HKD	-1,56 %		+2,15 %	-61,55 %

01/06	Les parlementaires américains demandent au FBI de leur fournir des informations sur les liens de GenScript Biotech avec la Chine	RE
31/05	Les parlementaires américains demandent au FBI de leur fournir des informations sur les liens de GenScript Biotech avec la Chine	RE

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

WuXi Biologics Enhances Manufacturing Capability with the Installation of Three 5,000L Single-Use Bioreactors	06/06
WuXi facility boosts bioprocessing capacity with new bioreactors	06/06
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	01/06
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	31/05
China stocks rise as industrial profits grow; energy, semiconductor shares lead gains	27/05
Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%	17/05
US House committee advances bill to restrict BGI, WuXi AppTec	15/05
US House committee to vote on bill to restrict BGI, WuXi AppTec	15/05
US Congress Drafts Bill Asking Drug Firms to Unlink from Chinese Biotech Firms	14/05
WuXi Shares Volatile as U.S. Bill Revised to Set Deadline for Decoupling	13/05
U.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut ties	10/05
Pacific Assets Trust cautiously optimistic after outpacing benchmark	30/04
WuXi Biologics Cayman : Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment	30/04
WuXi Biologics Selected for S&P Global Sustainability Yearbook 2024	16/04
WuXi Biologics Wins 2024 CDMO Leadership Awards in All Categories	03/04
Wuxi Biologics Inc. Announces Retirement of Weichang Zhou as Chief Technology Officer and President of Global Biologics Development and Operations and Re-Designates as Non-Executive Director and Honorary President of Global Biologics Development and Operations and Senior Advisor to Chief Executive Officer	01/04
WuXi Biologics Reports Solid 2023 Annual Results	27/03
WuXi Biologics' 2023 Profit Falls 23% Despite Revenue Jump	27/03
MÄRKTE ASIEN/Yen auf 34-Jahres-Tief stützt Kurse in Tokio	27/03
MÄRKTE ASIEN/Uneinheitlich - Schwacher Yen stützt Kurse in Tokio	27/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues WuXi Biologics (Cayman) Inc.

Actions

2269

KYG970081173

Autres langues

Filtres